Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase

被引:49
作者
Palaty, CK
ClarkLewis, I
Leung, D
Pelech, SL
机构
[1] UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER,BC V5Z 1A1,CANADA
[2] KINETEK PHARMACEUT INC,VANCOUVER,BC V5Z 1A1,CANADA
[3] UNIV BRITISH COLUMBIA,BIOMED RES CTR,VANCOUVER,BC V6T 1Z3,CANADA
[4] UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER,BC V6T 1Z3,CANADA
来源
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE | 1997年 / 75卷 / 02期
关键词
Pim-1; oncogene; protein kinase;
D O I
10.1139/bcb-75-2-153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pim-1 is an oncogene-encoded serine-threonine kinase that is expressed primarily in cells of the hematopoietic system and germ line. The full-length coding regions of both human and Xenopus laevis Pim-1 were expressed as recombinant bacterial fusion proteins that autophosphorylated in vitro and exhibited phosphotransferase activity towards various exogenous substrates. The consensus sequence for phosphorylation by Pim-1 was defined by stepwise replacement of the amino acids in peptide substrate analogues based on the carboxyl-terminal segment of human ribosomal protein S6 (residues 229-249). The optimal substrate peptide for Pim-1 was determined to be Lys/Arg-Lys/Arg-Arg-Lys/Arg-Leu-Ser/Thr-X where X is an amino acid residue with a small side chain. These results were confirmed using X. laevis Pim-1 expressed in COS cells. These findings could permit the identification of physiological substrates of Pim-1 and predict the location of phosphorylation sites within these proteins.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 61 条
[1]  
Acton D, 1992, Curr Top Microbiol Immunol, V182, P293
[2]   THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS [J].
AMSON, R ;
SIGAUX, F ;
PRZEDBORSKI, S ;
FLANDRIN, G ;
GIVOL, D ;
TELERMAN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8857-8861
[3]  
AOKI M, 1991, ONCOGENE, V6, P1515
[4]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[5]   PROVIRUS TAGGING AS AN INSTRUMENT TO IDENTIFY ONCOGENES AND TO ESTABLISH SYNERGISM BETWEEN ONCOGENES [J].
BERNS, A .
ARCHIVES OF VIROLOGY, 1988, 102 (1-2) :1-18
[6]   TUMORIGENESIS IN TRANSGENIC MICE - IDENTIFICATION AND CHARACTERIZATION OF SYNERGIZING ONCOGENES [J].
BERNS, A .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (02) :130-135
[7]  
BERNS A, 1988, ONCOGENE HDB, P121
[8]   VERY HIGH-FREQUENCY OF LYMPHOMA INDUCTION BY A CHEMICAL CARCINOGEN IN PIM-1 TRANSGENIC MICE [J].
BREUER, M ;
SLEBOS, R ;
VERBEEK, S ;
VANLOHUIZEN, M ;
WIENTJENS, E ;
BERNS, A .
NATURE, 1989, 340 (6228) :61-63
[9]  
BREUER M, 1991, CANCER RES, V51, P958
[10]   AN ACTIVE 20-AMINO-ACID-RESIDUE PEPTIDE DERIVED FROM THE INHIBITOR PROTEIN OF THE CYCLIC AMP-DEPENDENT PROTEIN-KINASE [J].
CHENG, HC ;
VANPATTEN, SM ;
SMITH, AJ ;
WALSH, DA .
BIOCHEMICAL JOURNAL, 1985, 231 (03) :655-661